Terminated NA INTERVENTIONAL 1-arm NCT00586807

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

Sponsor: ASPEN Rhoads Research Foundation

Conditions Energy Expenditure Protein Metabolism Ulcerative Colitis

Interventions Stable amino acid isotopes

Updated 5 times since 2017 Last updated: Jan 29, 2009 Started: Jun 30, 2005 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

poor enrollment

Other terminated trials from ASPEN Rhoads Research Foundation

Total Parenteral Nutrition-induced Cholestasis · Phase PHASE3 · Aug 2015

More terminations from ASPEN Rhoads Research Foundation

A NA clinical study on Energy Expenditure and Protein Metabolism, this trial is terminated or withdrawn. The trial is conducted by ASPEN Rhoads Research Foundation and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ASPEN Rhoads Research Foundation
Indiana University

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States